Kastrati A - Search Results

1

2018 ESC/EACTS Guidelines on myocardial revascularization.

Neumann FJ, Sousa-Uva M, Ahlsson A, Alfonso F, Banning AP, Benedetto U, Byrne RA, Collet JP, Falk V, Head SJ, Jüni P, Kastrati A, Koller A, Kristensen SD, Niebauer J, Richter DJ, Seferovic PM, Sibbing D, Stefanini GG, Windecker S, Yadav R, Zembala MO; ESC Scientific Document Group. Neumann FJ, et al. Among authors: kastrati a. Eur Heart J. 2019 Jan 7;40(2):87-165. doi: 10.1093/eurheartj/ehy394. Eur Heart J. 2019. PMID: 30165437 Free article. No abstract available.

2

Efficacy and safety of collagen implants for haemostasis of the vascular access site after coronary balloon angioplasty and coronary stent implantation. A randomized study.

von Hoch F, Neumann FJ, Theiss W, Kastrati A, Schömig A. von Hoch F, et al. Among authors: kastrati a. Eur Heart J. 1995 May;16(5):640-6. doi: 10.1093/oxfordjournals.eurheartj.a060967. Eur Heart J. 1995. PMID: 7588895 Clinical Trial.

3

Primary intracoronary stenting in acute myocardial infarction: long-term clinical and angiographic follow-up and risk factor analysis.

Kastrati A, Pache J, Dirschinger J, Neumann FJ, Walter H, Schmitt C, Schömig A. Kastrati A, et al. Am Heart J. 2000 Feb;139(2 Pt 1):208-16. doi: 10.1067/mhj.2000.102198. Am Heart J. 2000. PMID: 10650292

4

Improved clinical outcomes with abciximab therapy in acute myocardial infarction: a systematic overview of randomized clinical trials.

Kandzari DE, Hasselblad V, Tcheng JE, Stone GW, Califf RM, Kastrati A, Neumann FJ, Brener SJ, Montalescot G, Kong DF, Harrington RA. Kandzari DE, et al. Among authors: kastrati a. Am Heart J. 2004 Mar;147(3):457-62. doi: 10.1016/j.ahj.2003.08.011. Am Heart J. 2004. PMID: 14999194 Review.

5

Five-year outcome of patients with acute myocardial infarction enrolled in a randomised trial assessing the value of abciximab during coronary artery stenting.

Ndrepepa G, Kastrati A, Neumann FJ, Schmitt C, Mehilli J, Schömig A. Ndrepepa G, et al. Among authors: kastrati a. Eur Heart J. 2004 Sep;25(18):1635-40. doi: 10.1016/j.ehj.2004.04.031. Eur Heart J. 2004. PMID: 15351163 Clinical Trial.

6

One year outcomes with abciximab vs. placebo during percutaneous coronary intervention after pre-treatment with clopidogrel.

Schömig A, Schmitt C, Dibra A, Mehilli J, Volmer C, Schühlen H, Dirschinger J, Dotzer F, ten Berg JM, Neumann FJ, Berger PB, Kastrati A; Intracoronary Stenting and Antithrombotic Regimen-Rapid Early Action for Coronary Treatment Study Investigators. Schömig A, et al. Among authors: kastrati a. Eur Heart J. 2005 Jul;26(14):1379-84. doi: 10.1093/eurheartj/ehi174. Epub 2005 Feb 25. Eur Heart J. 2005. PMID: 15734767 Clinical Trial.

7

Abciximab in primary coronary stenting of ST-elevation myocardial infarction: a European meta-analysis on individual patients' data with long-term follow-up.

Montalescot G, Antoniucci D, Kastrati A, Neumann FJ, Borentain M, Migliorini A, Boutron C, Collet JP, Vicaut E. Montalescot G, et al. Among authors: kastrati a. Eur Heart J. 2007 Feb;28(4):443-9. doi: 10.1093/eurheartj/ehl472. Epub 2007 Jan 24. Eur Heart J. 2007. PMID: 17251257

8

A double-blind, randomized study on platelet aggregation in patients treated with a daily dose of 150 or 75 mg of clopidogrel for 30 days.

von Beckerath N, Kastrati A, Wieczorek A, Pogatsa-Murray G, Sibbing D, Graf I, Schömig A. von Beckerath N, et al. Among authors: kastrati a. Eur Heart J. 2007 Aug;28(15):1814-9. doi: 10.1093/eurheartj/ehl489. Epub 2007 Feb 1. Eur Heart J. 2007. PMID: 17272357 Clinical Trial.

9

One-year clinical outcomes with abciximab vs. placebo in patients with non-ST-segment elevation acute coronary syndromes undergoing percutaneous coronary intervention after pre-treatment with clopidogrel: results of the ISAR-REACT 2 randomized trial.

Ndrepepa G, Kastrati A, Mehilli J, Neumann FJ, ten Berg J, Bruskina O, Dotzer F, Seyfarth M, Pache J, Dirschinger J, Berger PB, Schömig A. Ndrepepa G, et al. Among authors: kastrati a. Eur Heart J. 2008 Feb;29(4):455-61. doi: 10.1093/eurheartj/ehm562. Epub 2007 Dec 23. Eur Heart J. 2008. PMID: 18158289 Clinical Trial.

10

Impact of bivalirudin or unfractionated heparin on platelet aggregation in patients pretreated with 600 mg clopidogrel undergoing elective percutaneous coronary intervention.

Sibbing D, Busch G, Braun S, Jawansky S, Schömig A, Kastrati A, Ott I, von Beckerath N. Sibbing D, et al. Among authors: kastrati a. Eur Heart J. 2008 Jun;29(12):1504-9. doi: 10.1093/eurheartj/ehn195. Epub 2008 May 7. Eur Heart J. 2008. PMID: 18467322 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

979 results

Search Page